|
First NxStage Home Hemodialysis Patients Celebrate Five-Year Anniversary (PR Newswire via Yahoo! Finance) |
NxStage Medical, Inc. , a leading manufacturer of innovative dialysis products, today announced that a group of its first patients are celebrating their five-year anniversary of home hemodialysis treatment with the NxStage® System One, the first truly portable home hemodialysis machine. read more |
|
Freezing organs could ease transplant panic - Buffalo News |
“One pig liver in a piggyback transplant is not very convincing, as there’s no evidence the thawed liver can really support the animal,” says David Winter, ... read more |
Phase III Trial Begins For GAMMAGARD LIQUID Plus RHuPH20 In Primary Immunodeficiency Patients (Medical News Today) |
Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze(TM) Technology) for the treatment of primary immunodeficiency (PID). read more |
RA Group Holdings completes acquisition of National Renal Alliance (Pharmaceutical Business Review) |
RA Group Holdings, the parent company of Renal Advantage and a provider of dialysis services, has completed its previously announced acquisition of Franklin, Tennessee-based National Renal Alliance. Terms of the transaction were not announced. read more |
XETRA-VERLAUF/DAX fest über 5.000 Pkt - Anleger unter Zugzwang - Frankfurter Allgemeine Zeitung |
Die als Dollar-sensitiv geltende Aktie von Fresenius Medical Care steigt um 2,2% auf 34,75 EUR. Der Euro ist inzwischen unter 1,34 USD und damit auf den ... read more |
|
|
|
<< Start < Prev 2441 2442 2443 2444 2445 2446 2447 2448 2449 2450 Next > End >>
|
Page 2446 of 2630 |